Kisspeptin-10 Dosage: A Beginner's Guide to Amounts and Timing

Built by medical professionals, gym rats, and experienced biohackers

Kisspeptin-10 is a short peptide fragment that sits upstream of the reproductive hormone chain, and doses are measured in micrograms rather than milligrams. Most research and community references describe situational or pulsatile timing rather than a fixed daily schedule. This guide covers what appears in the research literature and community discussions, not a prescription or protocol.

What Is Kisspeptin-10 and How Does It Work?

Kisspeptin-10 is the C-terminal 10-amino-acid fragment of the kisspeptin-54 protein, encoded by the KISS1 gene. It binds to a receptor called KISS1R (also known as GPR54), found on neurons in the hypothalamus.

When kisspeptin-10 activates KISS1R, it prompts the release of gonadotropin-releasing hormone (GnRH). GnRH then signals the pituitary to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH). This places kisspeptin-10 at the top of the main reproductive hormone cascade, which is why people approach it with more care than many other peptides.

It is sold as a research compound and is not approved as a medicine.

Why Does the Dose Unit Matter?

Kisspeptin-10 is dosed in micrograms (mcg), not milligrams. One microgram is one-thousandth of a milligram. That gap means a small measurement error has a larger proportional effect than with heavier peptides.

The molecular weight of kisspeptin-10 is approximately 1,302 daltons. This figure matters when researchers convert between molar units (nmol/kg, used in clinical studies) and the weight-based units (mcg per injection) that most community references cite.

Getting reconstitution math right is where beginners often go wrong. A tool like DoseVault handles the calculation automatically: enter your vial size, bacteriostatic water volume, and target dose, and it returns the exact draw volume in syringe units.

What Dose Ranges Appear in Human Research?

Human studies have used both intravenous and subcutaneous routes. IV bolus doses in published clinical research have ranged from roughly 0.3 to 10 nmol/kg body weight. Subcutaneous doses in studies tend to be higher than IV doses to account for the difference in bioavailability.

Researchers at academic institutions including Imperial College London have published work examining how different kisspeptin dose levels affect LH pulsatility in healthy volunteers and in people with hormonal conditions.

Community references, which are separate from clinical studies, tend to cite subcutaneous doses in a lower microgram range per injection, often single-digit to low double-digit micrograms. These figures should be treated as informal reference points only, not verified protocols. Beginners in community forums consistently report starting at the low end of any cited range and assessing response before making any adjustment.

When Do People Time Their Doses?

The plasma half-life of kisspeptin-10 is very short. Studies estimate clearance in the range of a few minutes after IV administration. That means continuous daily fixed dosing does not produce a steady-state blood level the way longer-acting peptides do.

Research has compared pulsatile and continuous infusion models, and pulsatile delivery (short bursts spaced apart) more closely mirrors how hypothalamic kisspeptin neurons fire naturally. Continuous infusion in some studies produced a blunted hormonal response compared to pulsatile delivery, a phenomenon called receptor desensitization.

In community discussions, most people describe situational or pre-activity timing rather than a rigid daily schedule. This pattern aligns with the underlying biology.

Does Hormonal Context Change the Approach?

Yes, significantly. Because kisspeptin-10 sits at the top of the reproductive hormone cascade, changes here can ripple downstream to LH, FSH, testosterone, and estrogen levels. This is why most research writeups and community discussions emphasize getting a baseline hormone panel before starting, and repeating it during use.

People with existing hormonal conditions, those on hormone replacement therapy, and anyone who is pregnant or breastfeeding are consistently advised to consult a clinician before approaching this compound. Individual hormonal baselines vary widely, which means responses at any given dose also vary.

How Do You Reconstitute and Track It?

Kisspeptin-10 typically arrives as a lyophilized (freeze-dried) powder in a sealed vial. You reconstitute it with bacteriostatic water and draw doses with an insulin syringe.

A simple example: a 1 mg vial with 2 mL of bacteriostatic water gives 0.5 mcg per microliter, or 50 mcg per 0.1 mL (10 units on a 100-unit insulin syringe). Real vial sizes and target doses vary, so the math changes each time.

Logging each dose, including the date, amount, time of day, and any observations, builds a record you can bring to a healthcare professional if you want a more informed conversation about your results.

FAQ

Is kisspeptin-10 FDA approved?
No. It is a research compound with no approved medical use anywhere.

Can I take it every day at a fixed time?
Most research protocols and community references do not use continuous daily fixed dosing, given the short half-life and the receptor desensitization seen in continuous-infusion studies.

Do men and women use different doses?
Published studies have included both male and female participants. Dosing in studies has varied by sex and hormonal status, but no community standard dose exists for either group.

How should I store it?
Lyophilized kisspeptin-10 is generally kept frozen before reconstitution and refrigerated after. Repeated freeze-thaw cycles degrade the peptide.

What if I have no hormone baseline?
Getting one before starting is the most common advice across research contexts and community forums. Without a baseline, you cannot tell whether anything changed.

Ready to log your doses and calculate exact draw volumes? Start tracking at DoseVault.

This article is for general educational purposes only. It does not diagnose, treat, cure, or prevent any condition. Speak with a licensed healthcare professional before using any research compound.